{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:38Z","timestamp":1786975598290,"version":"build-2736575974"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.3645","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T11:30:54Z","timestamp":1587727854000},"page":"e203645","source":"Crossref","is-referenced-by-count":47,"title":["Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women"],"prefix":"10.1001","volume":"3","author":[{"given":"Britton","family":"Trabert","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug C.","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana S. M.","family":"Buist","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Cauley","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni T.","family":"Falk","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M.","family":"Geczik","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Gierach","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manila","family":"Hada","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha F.","family":"Hue","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James V.","family":"Lacey","sequence":"additional","affiliation":[{"name":"Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Z.","family":"LaCroix","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Tice","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[{"name":"Leidos Biomedical Research Inc, Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cher M.","family":"Dallal","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Maryland College Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Brinton","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"issue":"5","key":"zoi200170r1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/jcem-63-5-1174","article-title":"Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture.","volume":"63","author":"Gompel","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"zoi200170r2","first-page":"23","article-title":"The correlation of histologic changes in the human breast with the menstrual cycle.","volume":"104","author":"Vogel","year":"1981","journal-title":"Am J Pathol"},{"issue":"2","key":"zoi200170r3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/bjc.1988.185","article-title":"The effect of age and menstrual cycle upon proliferative activity of the normal human breast.","volume":"58","author":"Potten","year":"1988","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi200170r4","first-page":"193","article-title":"Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.","volume":"130","author":"Going","year":"1988","journal-title":"Am J Pathol"},{"issue":"4","key":"zoi200170r5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-16-1717","article-title":"Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women.","volume":"77","author":"Sampson","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"zoi200170r6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/0008-5472.CAN-11-2507","article-title":"Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.","volume":"72","author":"Eliassen","year":"2012","journal-title":"Cancer Res"},{"issue":"2","key":"zoi200170r7","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz001","article-title":"Progesterone and breast cancer.","volume":"41","author":"Trabert","year":"2020","journal-title":"Endocr Rev"},{"issue":"9084","key":"zoi200170r8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer.","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"zoi200170r9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"9382","key":"zoi200170r10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"zoi200170r12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"issue":"6","key":"zoi200170r13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"zoi200170r14","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/jnci\/djh336","article-title":"Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.","volume":"96","author":"Missmer","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi200170r15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/hmbci-2015-0026","article-title":"Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry.","volume":"23","author":"Trabert","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"4","key":"zoi200170r16","first-page":"936","article-title":"The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion.","volume":"60","author":"Wiebe","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"zoi200170r17","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/bcr3422","article-title":"Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.","volume":"15","author":"Wiebe","year":"2013","journal-title":"Breast Cancer Res"},{"key":"zoi200170r18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2015.01.004","article-title":"Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5a-dihydroprogesterone (5aP) and can be suppressed by the 5a-reductase inhibitor, finasteride.","volume":"149","author":"Wiebe","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1-2","key":"zoi200170r19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jsbmb.2009.11.005","article-title":"Opposing actions of the progesterone metabolites, 5alpha-dihydroprogesterone (5alphaP) and 3alpha-dihydroprogesterone (3alphaHP) on mitosis, apoptosis, and expression of Bcl-2, Bax and p21 in human breast cell lines.","volume":"118","author":"Wiebe","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"zoi200170r20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1677\/erc.1.01010","article-title":"Progesterone metabolites in breast cancer.","volume":"13","author":"Wiebe","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"zoi200170r21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/carcin\/bgt367","article-title":"Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.","volume":"35","author":"Dallal","year":"2014","journal-title":"Carcinogenesis"},{"issue":"2","key":"zoi200170r22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2217\/17455057.4.2.151","article-title":"Progesterone and breast cancer.","volume":"4","author":"Lange","year":"2008","journal-title":"Womens Health (Lond)"},{"key":"zoi200170r23","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1007\/BF01623005","article-title":"Design of the Fracture Intervention Trial.","volume":"3","author":"Black","year":"1993","journal-title":"Osteoporos Int"},{"issue":"9041","key":"zoi200170r24","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"24","key":"zoi200170r25","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"issue":"24","key":"zoi200170r26","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"issue":"12","key":"zoi200170r27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","article-title":"Analysis of case-cohort designs.","volume":"52","author":"Barlow","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"zoi200170r28","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1210\/endo-127-5-2183","article-title":"Progesterone action in normal mouse mammary gland.","volume":"127","author":"Wang","year":"1990","journal-title":"Endocrinology"},{"issue":"37","key":"zoi200170r29","doi-asserted-by":"publisher","first-page":"14718","DOI":"10.1073\/pnas.0706933104","article-title":"Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.","volume":"104","author":"Feng","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"zoi200170r11","first-page":"393","volume-title":"Progestins and Antiprogestins in Clinical Practice","author":"Stanczyk","year":"2000"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2764844\/trabert_2020_oi_200170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T13:20:21Z","timestamp":1722777621000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2764844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3645","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}